PremiumThe FlyTrump admin plans to issue executive order on vaccines, autism, Bloomberg says7h agoAZNEBS
PremiumRatingsAstraZeneca: Buy Rating Reiterated on Attractive Valuation, Robust Pipeline, and Unchanged $16,500 Price Target8h agoAZN
AstraZeneca: Buy Rating Reiterated on Attractive Valuation, Robust Pipeline, and Unchanged $16,500 Price Target